Panbela Announces Poster Presentation at American Association for Cancer Research:
MINNEAPOLIS, April 18, 2024 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (OTCQB: PBLA)(“Panbela”), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announces a